{
  "slug": "l-arginine",
  "version": "1",
  "displayName": "L-arginine",
  "unit": "g",
  "doseKind": "compound",
  "ingredientGroups": [
    "Arginine"
  ],
  "shelfComparable": true,
  "primaryFloorId": "menafra-2022",
  "trialFloors": [
    {
      "id": "menafra-2022",
      "label": "Menafra 2022 (vasculogenic ED)",
      "presetLabel": "Menafra 2022",
      "amount": 6,
      "frequency": "daily",
      "horizon": "3 months",
      "evidenceLevel": "medium",
      "pmids": [
        "34973154"
      ],
      "n": 98,
      "note": "Multicentre double-blind RCT (51 arginine / 47 placebo) in vasculogenic ED. IIEF-6 and cavernous peak systolic velocity both improved, but only 24% reached scores compatible with no ED — mostly the mild-ED subgroup. High daily gram burden vs citrulline trials.",
      "effectDirection": "benefit",
      "funding": "independent"
    }
  ],
  "guideSlugs": [
    "l-citrulline-vs-l-arginine-for-ed",
    "nitric-oxide-ed-supplements",
    "supplements-for-ssri-induced-ed"
  ],
  "guideUrls": [
    "https://supplementbrief.com/l-citrulline-vs-l-arginine-for-ed/",
    "https://supplementbrief.com/nitric-oxide-ed-supplements/",
    "https://supplementbrief.com/supplements-for-ssri-induced-ed/"
  ],
  "shelf": {
    "registrySlug": "l-arginine",
    "label": "L-arginine",
    "productCount": 3121,
    "medianPerServing": 0.8,
    "p25PerServing": 0.3,
    "p75PerServing": 1.5,
    "belowPrimaryFloorPct": 99,
    "abovePrimaryFloorPct": 1,
    "unit": "g",
    "generatedAt": "2026-09-27T19:07:29.098Z",
    "source": "NIH DSLD bulk CSV (DietarySupplementFacts)"
  },
  "updatedDate": "2026-08-10",
  "dosePageUrl": "https://supplementbrief.com/dose/l-arginine/",
  "jsonUrl": "https://supplementbrief.com/data/v1/doses/l-arginine.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/doses/l-arginine/"
}
